Search Results - "Minzi, Omary Ms"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatment by Maganda, Betty A, Ngaimisi, Eliford, Kamuhabwa, Appolinary A R, Aklillu, Eleni, Minzi, Omary M S

    Published in Malaria journal (25-04-2015)
    “…HIV-malaria co-infected patients in most parts of sub-Saharan Africa are treated with both artemether-lumefantrine (AL) and efavirenz (EFV) or nevirapine…”
    Get full text
    Journal Article
  2. 2

    Pregnancy and CYP3A5 Genotype Affect Day 7 Plasma Lumefantrine Concentrations by Mutagonda, Ritah F, Minzi, Omary M S, Massawe, Siriel N, Asghar, Muhammad, Färnert, Anna, Kamuhabwa, Appolinary A R, Aklillu, Eleni

    Published in Drug metabolism and disposition (01-12-2019)
    “…Pregnancy and pharmacogenetics variation alter drug disposition and treatment outcome. The objective of this study was to investigate the effect of pregnancy…”
    Get full text
    Journal Article
  3. 3

    Efficacy of standardized extract of Hibiscus sabdariffa L. (Malvaceae) in improving iron status of adults in malaria endemic area: A randomized controlled trial by Peter, Emanuel L., Rumisha, Susan F., Mashoto, Kijakazi O., Minzi, Omary MS, Mfinanga, Sayoki

    Published in Journal of ethnopharmacology (14-09-2017)
    “…Indigenous community of Mkuranga district have been using aqueous extract of H. sabdariffa L. for treating anemia. However, there have been neither safety nor…”
    Get full text
    Journal Article
  4. 4

    Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations by Marwa, Karol J, Schmidt, Theresa, Sjögren, Maria, Minzi, Omary M S, Kamugisha, Erasmus, Swedberg, Göte

    Published in Malaria journal (03-11-2014)
    “…Artemisinin-based combinations currently recommended for treatment of uncomplicated Plasmodium falciparum malaria in many countries of sub-Saharan Africa are…”
    Get full text
    Journal Article
  5. 5

    Adherence to antiretroviral therapy among HIV infected children measured by caretaker report, medication return, and drug level in Dar Es Salaam, Tanzania by Mghamba, Frida William, Minzi, Omary M S, Massawe, Augustine, Sasi, Philip

    Published in BMC pediatrics (15-06-2013)
    “…Adherence to antiretroviral drugs in the treatment of paediatric HIV infection is complicated because of many factors including stigma and drug intake…”
    Get full text
    Journal Article
  6. 6

    Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy by Maganda, Betty A, Minzi, Omary M S, Kamuhabwa, Appolinary A R, Ngasala, Billy, Sasi, Philip G

    Published in Malaria journal (30-05-2014)
    “…Malaria and HIV infections are both highly prevalent in sub-Saharan Africa, with HIV-infected patients being at higher risks of acquiring malaria. The majority…”
    Get full text
    Journal Article
  7. 7

    Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania by Joseph, Deokary, Kabanywanyi, Abdunoor M, Hulser, Ruth, Premji, Zulfiqarali, Minzi, Omary Ms, Mugittu, Kefas

    Published in Malaria journal (11-02-2013)
    “…Tanzania adopted artemether-lumefantrine (AL) as first-line drug for uncomplicated malaria in 2006. Recently, there was an anecdotal report on high malaria…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania by Mugusi, Sabina F, Ngaimisi, Eliford, Janabi, Mohamed Y, Mugusi, Ferdinand M, Minzi, Omary M S, Sasi, Philip G, Bakari, Muhammad, Lindquist, Lars, Aklillu, Eleni, Sandstrom, Eric G

    Published in Antiviral therapy (01-01-2012)
    “…The aim of this study was to describe risk factors for mortality and clinical characteristics of HIV-infected patients with and without tuberculosis (TB)…”
    Get more information
    Journal Article
  10. 10

    Adoption of the new antimalarial drug policy in Tanzania – a cross‐sectional study in the community by Eriksen, Jaran, Nsimba, Stephen E. D., Minzi, Omary M. S., Sanga, Anku J., Petzold, Max, Gustafsson, Lars L., Warsame, Marian Y., Tomson, Göran

    Published in Tropical medicine & international health (01-10-2005)
    “…Summary Objective  To assess the diffusion of the change of first line antimalarial drug from chloroquine (CQ) to sulphadoxine/pyrimethamine (SP) at household…”
    Get full text
    Journal Article
  11. 11